Results 141 to 150 of about 663,256 (217)

Gemcitabine + Cisplatin + S-1 Treatment for Advanced Cholangiocarcinoma: Cost-Effective, with Better Progression-Free Survival Versus Standard Treatment with Gemcitabine + Cisplatin + Durvalumab. [PDF]

Cancers (Basel)
Morita Y, Sugimoto R, Kurokawa M, Tanaka Y, Senju T, Ichimaru T, Lee L, Niina Y, Hisano T, Furukawa M, Sugimachi K, Tanaka M.   +11 more
europepmc   +1 more source

Predictors of response, progression‐free survival, and overall survival using NANT Response Criteria (v1.0) in relapsed and refractory high‐risk neuroblastoma

, 2018
Judith G. Villablanca, Lingyun Ji, Adi Shapira‐Lewinson, Araz Marachelian, Hiroyuki Shimada, Randall A. Hawkins, Miguel Hernandez Pampaloni, Hollie Lai, Fariba Goodarzian, Richard Sposto, Julie R. Park, Katherine K. Matthay   +11 more
openalex   +2 more sources

Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in De Novo Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study. [PDF]

Cancer Res Commun
Wang R, Xu J, Zhu C, Liu W, Jin C, Luo W, Zhao T, Guo C, Chen W, Yang B.   +9 more
europepmc   +1 more source

Effect of Conization Prior to Radical Hysterectomy on Overall and Progression-Free Survival in Early-Stage Cervical Cancer: A Propensity Score-Matched Analysis. [PDF]

Cancers (Basel)
Rachadech N, Phookiaw S, Charoenkwan K.
europepmc   +1 more source

Predictive Value of the KELIM Index for Progression-Free Survival in Ovarian Cancer Under Current Treatment Modalities. [PDF]

Int J Womens Health
Lv J, Xu Y, Zeng C, Huang F, Tao S.
europepmc   +1 more source

Predicting Progression-free Survival in Primary Liver Cancer Patients via Radiomics from DSA during TACE [PDF]

Yongfa Liu, Cheng Cui, Benjian Gao, Bin Luo, Fangyi Peng, Shuai Hu, Linxin Liu, Xue-cheng Bai, Yaling Li, Xiaoli Yang, Bo Li   +10 more
openalex   +1 more source

A randomized Bayesian phase I-II dose optimization design for combination cancer therapies with progression-free survival end point. [PDF]

BMC Med Res Methodol
Qiu Y, Li M.
europepmc   +1 more source

Irinotecan chemotherapy combined with fluoropyrimidines versus irinotecan alone for overall survival and progression-free survival in patients with advanced and/or metastatic colorectal cancer

, 2016
Wahyu Wulaningsih, Ardyan Wardhana, Johnathan Watkins, Naomi Yoshuantari, Dimitra Repana, Mieke Van Hemelrijck   +5 more
openalex   +2 more sources

How to predict progression-free survival in patients with grade 2 IDH-mutated diffuse gliomas after surgery: a long-term follow-up analysis. [PDF]

Front Oncol
Aprile M, Di Nunno V, Gatto L, Tosoni A, Balestrini D, Ramponi V, Conti A, Maffei M, Battaglia S, Argento CM, Zuliani E, Bartolini S, Margotti M, Gentilini F, Tallini G, Asioli S, Franceschi E.   +16 more
europepmc   +1 more source